Vladimir Lazarevic
21 – 30 of 86
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Acute myeloid leukemia in patients we judge as being older and/or unfit
- Contribution to journal › Scientific review
-
Mark
Comparison of RNA- and DNA-based methods for measurable residual disease analysis in NPM1-mutated acute myeloid leukemia
(2021) In International Journal of Laboratory Hematology
- Contribution to journal › Article
-
Mark
Parental origin of monosomy 7 in acute leukaemia
(2021) In British Journal of Haematology
- Contribution to journal › Letter
-
Mark
Impact of treatment delay in acute myeloid leukemia revisited
- Contribution to journal › Debate/Note/Editorial
-
Mark
Clinical and genomic characterization of patients diagnosed with the provisional entity Acute myeloid leukemia with BCR-ABL1, a Swedish population-based study
- Contribution to journal › Article
- 2020
-
Mark
Decreasing early mortality in acute myeloid leukaemia in Sweden 1997–2014 : improving performance status is a major contributing factor
- Contribution to journal › Letter
-
Mark
The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting
- Contribution to journal › Article
-
Mark
Real-world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged ≥ 60 years
- Contribution to journal › Letter
-
Mark
Clonal competition within complex evolutionary hierarchies shapes AML over time
- Contribution to journal › Article
-
Mark
Why classical cytogenetics still matters in acute myeloid leukemia
- Contribution to journal › Debate/Note/Editorial
